Citadel Advisors
VTAK icon

Citadel Advisors’s Catheter Precision VTAK Stock Holding History

Citadel Advisors’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,771
Closed -$23.4K – 14345
2025
Q4 		$23.4K Buy
+12,771
New +$29.4K ﹤0.01% 12305
2025
Q3 		– Sell
-6,363
Closed -$29.3K – 14246
2025
Q2 		$29.3K Buy
6,363
+4,628
+267% +$25.1K ﹤0.01% 11992
2025
Q1 		$11.3K Buy
+1,735
New +$13.1K ﹤0.01% 13493
2024
Q3 		– Sell
-115
Closed -$12.7K – 15344
2024
Q2 		$12.7K Buy
+115
New +$11.7K ﹤0.01% 12970
2023
Q3 		– Sell
-92
Closed -$16.1K – 15207
2023
Q2 		$16.1K Buy
+92
New +$21.2K ﹤0.01% 12912
2023
Q1 		– Sell
-90
Closed -$101K – 15587
2022
Q4 		$101K Buy
+90
New +$74.6K ﹤0.01% 11206
2022
Q1 		– Sell
-5
Closed -$68K – 14672
2021
Q4 		$68K Buy
5
+3
+150% +$71.5K ﹤0.01% 13053
2021
Q3 		$67K Buy
+2
New +$62.9K ﹤0.01% 13188
2021
Q2 		– Sell
-1
Closed -$59K – 14516
2021
Q1 		$59K Hold
1
– – ﹤0.01% 12816
2020
Q4 		$93K Buy
+1
New +$59.5K ﹤0.01% 10268
2020
Q3 		– Hold
0
– -$10K – 10804
2020
Q2 		– Hold
0
– – – 9637
2020
Q1 		– Hold
0
– – – 9316
2019
Q4 		– Hold
0
– – – 8977
2019
Q3 		– Hold
0
– – – 8908
2019
Q2 		– Hold
0
– -$46K – 9924
2019
Q1 		– Hold
0
– – – 8854
2018
Q4 		– Hold
0
– – – 8166
2018
Q3 		– Hold
0
– – – 6508

Other funds holding VTAK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.42B AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Citadel Advisors's VTAK Position: Q1 2026 in Review

Citadel Advisors sold out of Catheter Precision (VTAK) in Q1 2026, closing a stake of 12,771 shares — an estimated $23.4K sold.

Citadel Advisors first reported a position in VTAK in Q4 2020 and held it in 10 quarters. The position peaked at $101K in Q4 2022. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Citadel Advisors reported no remaining Catheter Precision position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 12,771 Catheter Precision shares in Q1 2026, an estimated $23.4K.
  • Citadel Advisors first reported a position in Catheter Precision in Q4 2020 and held it in 10 quarters.
  • Citadel Advisors's Catheter Precision position peaked at $101K in Q4 2022.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.